Effect of Vaccination with Carrier Protein on Response to Meningococcal C Conjugate Vaccines and Value of Different Immunoassays as Predictors of Protection

In order to plan for the wide-scale introduction of meningococcal C conjugate (MCC) vaccine for United Kingdom children up to 18 years old, phase II trials were undertaken to investigate whether there was any interaction between MCC vaccines conjugated to tetanus toxoid (TT) or a derivative of dipht...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Burrage, Moya, Robinson, Andrew, Borrow, Ray, Andrews, Nick, Southern, Joanna, Findlow, Jamie, Martin, Sarah, Thornton, Carol, Goldblatt, David, Corbel, Michael, Sesardic, Dorothea, Cartwight, Keith, Richmond, Peter, Miller, Elizabeth
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2002
Matèries:
Microbial Immunity and Vaccines
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC128295/
https://ncbi.nlm.nih.gov/pubmed/12183540
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/IAI.70.9.4946-4954.2002
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars